A detailed history of Janus Henderson Group PLC transactions in Bio Techne Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 997,166 shares of TECH stock, worth $71.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
997,166
Previous 1,106,487 9.88%
Holding current value
$71.1 Million
Previous $79.3 Million 0.51%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$70.96 - $82.35 $7.76 Million - $9 Million
-109,321 Reduced 9.88%
997,166 $79.7 Million
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $6.87 Million - $9.31 Million
110,663 Added 11.11%
1,106,487 $79.3 Million
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $857,146 - $1 Million
12,991 Added 1.32%
995,824 $70.1 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $36,399 - $53,893
689 Added 0.07%
982,833 $75.8 Million
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $294,387 - $389,871
-4,360 Reduced 0.44%
982,144 $66.9 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $221,280 - $257,940
-3,000 Reduced 0.3%
986,504 $80.5 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $226,462 - $273,892
3,162 Added 0.32%
989,504 $73.4 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $59.5 Million - $260 Million
737,179 Added 295.86%
986,342 $81.7 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $41,815 - $57,993
-148 Reduced 0.06%
249,163 $70.8 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $7.9 Million - $11 Million
-24,494 Reduced 8.95%
249,311 $86.4 Million
Q1 2022

May 16, 2022

SELL
$353.85 - $487.79 $25.6 Million - $35.3 Million
-72,428 Reduced 20.92%
273,805 $119 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $2.34 Million - $2.69 Million
5,119 Added 1.5%
346,233 $179 Million
Q3 2021

Nov 16, 2021

SELL
$444.87 - $538.88 $28.7 Million - $34.7 Million
-64,443 Reduced 15.89%
341,114 $165 Million
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $45.8 Million - $53.2 Million
-118,161 Reduced 22.56%
405,557 $183 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $19.2 Million - $25.1 Million
-60,967 Reduced 10.43%
523,718 $200 Million
Q4 2020

Feb 16, 2021

SELL
$246.9 - $321.87 $38.5 Million - $50.3 Million
-156,136 Reduced 21.08%
584,685 $186 Million
Q3 2020

Nov 16, 2020

SELL
$232.22 - $282.96 $23.6 Million - $28.7 Million
-101,516 Reduced 12.05%
740,821 $184 Million
Q2 2020

Aug 14, 2020

SELL
$185.43 - $279.56 $1.42 Million - $2.15 Million
-7,683 Reduced 0.9%
842,337 $222 Million
Q1 2020

May 14, 2020

SELL
$161.17 - $221.51 $59.2 Million - $81.4 Million
-367,475 Reduced 30.18%
850,020 $161 Million
Q4 2019

Feb 18, 2020

SELL
$189.68 - $222.09 $20.1 Million - $23.5 Million
-105,907 Reduced 8.0%
1,217,495 $267 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $10.6 Million - $12.5 Million
-57,534 Reduced 4.17%
1,323,402 $259 Million
Q2 2019

Jul 31, 2019

SELL
$188.72 - $215.43 $4.53 Million - $5.17 Million
-24,015 Reduced 1.71%
1,380,936 $288 Million
Q1 2019

Apr 30, 2019

SELL
$136.09 - $200.44 $4.85 Million - $7.14 Million
-35,625 Reduced 2.47%
1,404,951 $279 Million
Q4 2018

Feb 06, 2019

BUY
$132.75 - $203.8 $6.33 Million - $9.72 Million
47,689 Added 3.42%
1,440,576 $208 Million
Q3 2018

Nov 09, 2018

SELL
$147.44 - $204.11 $20,641 - $28,575
-140 Reduced 0.01%
1,392,887 $284 Million
Q2 2018

Aug 10, 2018

BUY
$144.9 - $165.58 $11.1 Million - $12.7 Million
76,538 Added 5.81%
1,393,027 $206 Million
Q1 2018

May 14, 2018

BUY
$131.46 - $151.04 $10.7 Million - $12.3 Million
81,110 Added 6.57%
1,316,489 $199 Million
Q4 2017

Feb 09, 2018

BUY
$121.17 - $134.75 $13.5 Million - $15 Million
111,679 Added 9.94%
1,235,379 $160 Million
Q3 2017

Nov 14, 2017

SELL
$113.59 - $123.78 $7.32 Million - $7.97 Million
-64,408 Reduced 5.42%
1,123,700 $0
Q2 2017

Aug 17, 2017

BUY
N/A
1,188,108
1,188,108 $140 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.